)
Visual
test
Mabion
Mabion (MAB) investor relations material
Mabion Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary1 Dec, 2025
Executive summary
Report covers 3 and 9 months ended September 30, 2025, prepared under IFRS and going concern principle.
Company operates as a CDMO, focusing on contract development and manufacturing of biological drugs, with updated strategy for 2025-2030 emphasizing technological development, operational excellence, and human capital.
Key contracts executed with Novavax, Novalgen Ltd (UK), Instituto De Biologia Molecular Do Paraná (Brazil), and WPD Pharmaceuticals.
Significant management changes occurred in Q3 2025, including new appointments and resignations.
Financial highlights
Revenue for 9M 2025: PLN 10,061k, down sharply from PLN 64,269k in 9M 2024.
Net loss for 9M 2025: PLN (41,425)k, compared to net profit of PLN 11,539k in 9M 2024.
Gross loss on sales for 9M 2025: PLN (14,386)k, versus gross profit of PLN 53,211k in 9M 2024.
Cash and cash equivalents at September 30, 2025: PLN 4,608k, down from PLN 38,448k at December 31, 2024.
Total assets: PLN 120,456k; total equity: PLN 70,017k; total liabilities: PLN 50,439k as of September 30, 2025.
Outlook and guidance
Management expects additional contracts to be signed to secure liquidity, but current contracts and pipeline are insufficient for 12-month liquidity.
Immediate additional financing is required; bridge loan and share issue planned to support operations.
New strategy for 2025-2030 aims to strengthen CDMO position and acquire new biosimilar and innovative product contracts.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Mabion
- Revenue and profit fell as Novavax production ended, but new contracts and stable cash support operations.MAB
Q3 202411 Mar 2026 - Sharp revenue drop and net loss drive urgent capital raise and bridge loan for liquidity.MABQ2 202511 Mar 2026
- H1 2024 saw lower profits as Novavax production ended, but new CDMO contracts drive future growth.MABQ2 202411 Mar 2026
- Completed CDMO transformation, posted a net loss, and updated strategy amid new contracts and risks.MABQ4 202411 Mar 2026
- Significant revenue drop and net loss in Q1 2025, with urgent need for new contracts and financing.MABQ1 202511 Mar 2026
Next Mabion earnings date
Q4 202521 Apr, 2026
Mabion
Next Mabion earnings date
Q4 202521 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage